When Endometriosis Surgery “Fails”: Why Pain Persists and What’s Next

Endometriosis surgery is often presented as either the initial "cornerstone" therapy or in some cases as the “next step” when symptoms don’t respond to medication. The sequence depends on who is consulting (specialist or not), if fertility is a goal, or when imaging suggests advanced disease. But many patients eventually find themselves eventually searching phrases like “endometriosis surgery failed” or “pain after endometriosis surgery”—not because they regret seeking care, but because they’re still hurting, still missing work, still avoiding sex, still living around symptoms.

If this is you, it’s important to know that “failed surgery” is not one single scenario. Across all research publications, a meaningful subset of patients report incomplete symptom relief after surgery, some need additional operations, and surgical complications—while uncommon in most settings—can be life-altering when they occur (Singh et al., 2020; Pickett et al., 2023). The most helpful next steps depend on which “failure pattern” you’re actually experiencing.

This article synthesizes findings from multiple studies to help you define what happened, understand common mechanisms, and plan a rational path forward—without blaming your surgeon or yourself and without assuming your only option is “just do another surgery.”

What does “failed endometriosis surgery” actually mean?

Most patients use “failed” to mean “I still have pain.” Clinically, it helps to separate three different outcomes, because the causes (and solutions) are different:

1) Surgical adverse event (a complication).

This means the surgery created a new medical problem (or worsened function), such as infection, bleeding, bowel injury, urinary tract injury, fistula, prolonged bladder dysfunction or any number of rare events. Studies of complex disease involving bowel, bladder, or ureters show that complications can be significant, including urinary fistulas and prolonged bladder emptying problems in some patients (Rozsnyai et al., 2011). In large colorectal endometriosis datasets, severe complications (grade III–V) are reported in the single-digit percentages, with specific risks such as pelvic abscess and rectovaginal fistula (Bendifallah et al., 2018). This is certainly not “your body failing”—it’s a recognized surgical risk profile that varies by procedure complexity and setting. While some of these risks can be reduced, many cannot because the nature of this type of surgery is highly variable.

2) Persistent symptoms from incomplete treatment effect (the surgery didn’t achieve its goal).

Here, pain never meaningfully improved, or it improved briefly and returned within weeks to a few months. This pattern often points to incomplete endometriosis excision (residual disease), missed disease locations, disease that required a different surgical strategy than what was performed, or a non-endometriosis pain generator that wasn’t addressed. A systematic review found that after appropriate and seemingly complete excision of visible lesions, about 11.8% reported no pain improvement, underscoring that even well-intended surgery does not guarantee relief (Singh et al., 2020).

3) True disease recurrence (new or returning disease months to years later).

This is real, but it’s a different category than “the surgery didn’t work.” Recurrence is influenced by biology and time. In real-world care, reoperation rates accumulate over years (Pickett et al., 2023). We’ll only reference recurrence here as a boundary, since prevention and long-term suppression strategies are covered elsewhere in this series.

If you’re not sure which category fits, you’re not alone—and the operative report, pathology report, and a careful symptom timeline usually clarify it.

Why endometriosis surgery “didn’t work”: the most common mechanisms

Persistent symptoms are rarely explained by a single factor. Research and surgical reviews consistently point to several mechanisms that can overlap.

Incomplete excision / residual disease (including “microscopic” or hard-to-see disease)

Endometriosis can be visually subtle, hidden under fibrosis, or located in areas that aren’t fully assessed in a limited pelvic survey. Surgical reviews emphasize that “complete resection” is a goal associated with better symptom control, but it’s constrained by lesion detectability and by safety when disease is near nerves, bowel, bladder, or ureters (Rimbach et al., 2013). Put simply: even a technically careful surgery can leave behind disease when margins are unclear or anatomy is distorted.

This is one reason “incomplete endometriosis excision” is so commonly discussed by patients after surgery: not because surgeons are careless, but because the disease can exceed what is obvious to the eye, and deeper disease patterns can be difficult to distinguish from scarring until you’re in the right surgical plane. Obviously the level of surgical expertise plays a big role but without removing a lot of normal appearing tissue, structures and even organs, microscopic disease is highly likely to be left behind. Microscopic disease may or may not grow back over time (depending on suppression effectiveness) but this is usually measurable in years and not months. If there is a short term recurrence, it is more likely that macro (visible) disease was not recognized and hence not excised.

The technique didn’t match the disease pattern encountered

Without re-litigating “excision vs ablation” as a general debate (covered earlier in this series), it’s still true that a technique can be insufficient for the lesion type. Deep infiltrating endometriosis (DIE) involving bowel, bladder, ureters, or parametrial spaces usually require approaches that go beyond superficial treatment. In a large single-center experience where most patients had advanced-stage disease, pain scores improved for most—but average pain after surgery remained in the moderate range for many, highlighting that “doing surgery” and “fully resolving the pain generator” are not always the same thing (Alborzi et al., 2017).

Regarding use of ablation, one thing we know from almost a 100 years of surgical experience is that the evidence strongly supports minimizing thermal injury, using judicious rather than extensive cautery, and favoring excision over ablation for that reasons. Fibrosis from extensive ablation leads to molecular signal recruitment of nerve endings in area, which can lead to increased pain after surgery.

Similarly, when surgery involves bowel, the specific method used during the operation (for example, disc or segmental resection) strongly influences risk and recovery. In a cohort analyzing subsequent surgeries, major postoperative complications were more linked to whether bowel resection was performed than to whether the patient had prior surgeries (Tummers et al., 2023). That matters because sometimes a first surgery avoids needed steps, and a later surgery becomes more complex.

Missed locations (disease outside the “standard” operative field)

A recurring theme across surgical literature is that endometriosis is not confined to ovaries or the superficial pelvis. In the Alborzi surgical series, a notable portion had DIE or peritoneal disease without endometrioma—supporting that absence of an ovarian endometriotic cyst does not rule out deeper or extra-ovarian disease (Alborzi et al., 2017). When disease involves the urinary tract, surgical series show that additional organs are frequently involved and that combined operations may be required (Rozsnyai et al., 2011). If the first surgery did not evaluate or treat those sites, persistent symptoms can follow.

Unrecognized co-existing conditions (the endometriosis was real, but not the whole story)

Modern care reviews argue that an “acute-care, surgery-only” model often fails endometriosis patients because pain and quality-of-life impacts extend beyond lesion removal alone (Pickett et al., 2023). Persistent pelvic pain can be amplified by pelvic floor dysfunction, bladder pain syndromes, bowel disorders, adenomyosis, or central sensitization/nociplastic pain processes. In these cases, the surgery may have removed endometriosis appropriately—yet symptoms persist because the dominant pain driver wasn’t endometriosis (or wasn’t only endometriosis).

This is also why “normal imaging” doesn’t end the conversation: ultrasound and MRI can help for endometriomas and some deep disease, but can often miss superficial implants, and imaging is not a direct measure of pain mechanisms (Pickett et al., 2023).

Surgery itself can create new pain generators

Even when endometriosis is treated, surgery can introduce new issues: adhesions, fibrosis, nerve growth and irritation, altered organ motility, or reduced ovarian reserve after endometrioma surgery. Surgical reviews explicitly warn about the fertility/ovarian-function trade-offs of endometrioma excision and the potential for voiding dysfunction when operating near pelvic nerves in deep disease (Rimbach et al., 2013). For urinary tract DIE, postoperative functional problems such as prolonged bladder atony/denervation were reported in some patients (Rozsnyai et al., 2011). These are not common outcomes for everyone—but when present, they change what “next step” makes sense.

What research says about reoperation and why outcomes vary

When patients say “endometriosis surgery didn’t work,” a key question is whether the outcome you’re having is common enough to be predictable—and whether it’s linked to modifiable factors.

A systematic review of surgical outcomes found two sobering realities: many studies don’t consistently report the outcomes patients care about (pain, recurrent pain, repeat surgery), and a meaningful minority still have pain or go on to further surgery (Singh et al., 2020). In other words, persistent symptoms are not rare anecdotes; they show up in aggregated data.

At the same time, studies looking at surgical complexity and repeat operations show why “another surgery” isn’t a simple reset. In a cohort where almost half had prior endometriosis surgery, repeat operations were common, and the median interval since last surgery was about three years (Tummers et al., 2023). Prior open endometriosis surgery (laparotomy) was associated with longer operative times and more adhesiolysis at the next surgery, and higher odds of intra-operative complications—suggesting that prior surgical approach and scarring can make subsequent surgery more complex (Tummers et al., 2023). Again, an ablation surgery is more likely to lead to fibrosis, making the next surgery that much more challenging and risky.

Complexity also depends on what organs are involved. For example, urinary tract DIE surgery can be effective in symptom control in selected patients, but reported complications—like fistulas or prolonged bladder emptying issues—illustrate why careful planning and appropriate specialty involvement matters (Rozsnyai et al., 2011).

Surgeon and center experience: one of the clearest “system-level” signals

Even when two patients have “the same diagnosis,” outcomes can differ depending on where and by whom surgery is performed—especially for bowel and other deep disease.

More recent population-level evidence also supports the relationship between surgeon volume and outcomes in endometriosis surgery overall. In a large cohort study, most patients had surgery performed by low-volume surgeons, while higher-volume surgeons had lower short-term complication rates and patients were less likely to undergo repeat surgery (Bougie et al., 2025). While volume is not the only measure of skill, across studies it repeatedly correlates with outcomes that patients feel as “failure”: complications, persistent symptoms that drive reoperation, and the need for additional procedures.

This is not about perfection—it’s about probabilities. When surgery is complex, small differences in mapping, plane-finding, nerve-sparing, and multidisciplinary coordination when it is needed can compound into meaningful differences in residual disease and postoperative function. The surgeon should not just be "high volume," if most are straightforward cases or high volume where only a small portion are endo-related. The surgeon should be one that has extensive experience in a range of simpler to difficult complex cases, which facilitates not only the risk of complications but also choice of the right procedure in the situation at hand. For example, some teams approach rectal disease as a one size fits all rectal resection which is not the first choice for many reasons, especially where optimizing fertility is a concern. Decision-making regarding the best option for the findings at hand requires experience and not just rote technical execution.

Robotic vs laparoscopic surgery: can approach explain “failure”?

Patients sometimes wonder if their outcome would have been different with robotic surgery. The best current synthesis suggests that robotic-assisted laparoscopy is often comparable to conventional laparoscopy on major perioperative outcomes, but may take longer, and evidence of long-term symptom superiority is limited (Lee & Kim, 2024). For deep infiltrating disease, a meta-analysis summarized in that review found similar complication and conversion rates (Lee & Kim, 2024). However, there are other publications which are supportive of robotics due to obvious technical advantages. At the end of the day, these are just tools and surgeon experience is the main factor.

Where robotics may matter is in select scenarios, such as technically confined spaces or ovarian-tissue preservation questions during endometrioma surgery—but the evidence cited is small and not definitive (Lee & Kim, 2024). In practice, persistent pain after surgery is more often explained by disease biology, mapping/completeness, co-existing pain drivers, and multidisciplinary planning than by robotics alone.

What to do if your endometriosis surgery failed (practical next steps)

The goal is to move from “something went wrong” to a clearer, testable explanation. A limited number of steps usually create the most clarity.

• Reconstruct your timeline and classify the pattern. If pain never improved, think residual disease, missed sites, or non-endo pain generators. If pain improved and then returned quickly, consider incomplete treatment effect or early return of inflammation. If a new symptom started right after surgery (new urinary retention, new bowel urgency/incontinence, new neuropathic pain), prioritize complication or nerve/adhesion-related causes.

• Get a formal review of your operative report and pathology. A common gap in real-world care is not having standardized, patient-relevant outcomes and documentation (Pickett et al., 2023; Singh et al., 2020). Knowing what was actually treated (and what was not assessed) is often more helpful than repeating imaging immediately.

• If redo surgery is being considered, treat it as a different operation—not “the same surgery again.” Repeat surgery may involve adhesions, fibrosis and altered tissue planes. Prior open endometriosis surgery, in particular, has been associated with higher operative complexity and intra-operative complication odds during subsequent surgery (Tummers et al., 2023). This is one reason second surgeries often require more planning and sometimes additional specialties (colorectal/urology) rather than less.

• Evaluate co-existing conditions in parallel. Persistent pain after endometriosis surgery is not proof that “surgery failed.” It can be a sign that endometriosis wasn’t the dominant driver (or isn’t anymore). Multidisciplinary chronic-care models—pelvic floor physical therapy, pain medicine, mental health support, GI/urology when indicated—are specifically proposed as a way to address overlapping pain mechanisms and quality-of-life impacts (Pickett et al., 2023).

What we still don’t know (and why your outcome may differ from someone else’s)

Even in 2026, the evidence base has gaps that directly affect patients:

• Outcome reporting is inconsistent. A large portion of studies in surgical reviews don’t report key outcomes like pain trajectories and repeat surgery in a way that allows accurate comparisons (Singh et al., 2020). This makes it harder to predict your individual odds.

• “Endometriosis pain” is not one entity. Research and clinical reviews increasingly frame endometriosis as a chronic inflammatory condition with broad impacts beyond lesions, and that reality complicates the idea that surgery alone can “fix” every symptom (Pickett et al., 2023).

• Complex surgeries have center-dependent results. Complication risks for bowel/urinary tract disease vary with procedure type and experience levels (Bendifallah et al., 2018; Rozsnyai et al., 2011), so statistics from one setting may not apply to another.

Closing: where this fits in the Surgery Guide series

This final post exists because many patients arrive here despite doing “everything right.” If you’re searching “endometriosis surgery didn’t work,” consider a framework that separates complications from persistent disease from recurrence, and that gives you a path forward grounded in evidence rather than guesswork.

The earlier posts in this series focus on choices that can reduce the chance of ending up in this situation. But if you are already here, the next best step is clarity: define the type of “failure,” identify the most likely mechanism(s), and build a plan that addresses both endometriosis and the other treatable drivers of pelvic pain and quality of life.